| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 1543 | 2021 |
| Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study H Gacaferi, GS Collaborative, COVIDSurg Collaborative Anaesthesia 76 (6), 2021 | 537* | 2021 |
| Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study RA Evans, H McAuley, EM Harrison, A Shikotra, A Singapuri, M Sereno, ... The Lancet Respiratory Medicine 9 (11), 1275-1287, 2021 | 479 | 2021 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 371* | 2021 |
| Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10274), 605, 2021 | 317 | 2021 |
| Pregnancy and neonatal outcomes of COVID‐19: coreporting of common outcomes from PAN‐COVID and AAP‐SONPM registries E Mullins, ML Hudak, J Banerjee, T Getzlaff, J Townson, K Barnette, ... Ultrasound in Obstetrics & Gynecology 57 (4), 573-581, 2021 | 308 | 2021 |
| Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 399 (10320), 143, 2022 | 307* | 2022 |
| Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a … C Jin, MM Gibani, M Moore, HB Juel, E Jones, J Meiring, V Harris, ... The Lancet 390 (10111), 2472-2480, 2017 | 303 | 2017 |
| Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study RA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ... The Lancet Respiratory Medicine 10 (8), 761-775, 2022 | 289 | 2022 |
| Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial GE Thwaites, M Scarborough, A Szubert, E Nsutebu, R Tilley, J Greig, ... The Lancet 391 (10121), 668-678, 2018 | 177 | 2018 |
| Safety and efficacy of a typhoid conjugate vaccine in Malawian children PD Patel, P Patel, Y Liang, JE Meiring, T Misiri, F Mwakiseghile, JK Tracy, ... New England Journal of Medicine 385 (12), 1104-1115, 2021 | 106 | 2021 |
| SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study. C COVIDSurg, C GlobalSurg Anaesthesia 77 (1), 28-39, 2022 | 100 | 2022 |
| The STRATAA study protocol: a programme to assess the burden of enteric fever in Bangladesh, Malawi and Nepal using prospective population census, passive surveillance … TC Darton, JE Meiring, S Tonks, MA Khan, F Khanam, M Shakya, ... BMJ open 7 (6), e016283, 2017 | 72 | 2017 |
| Burden of enteric fever at three urban sites in Africa and Asia: a multicentre population-based study JE Meiring, M Shakya, F Khanam, M Voysey, MT Phillips, S Tonks, ... The Lancet Global Health 9 (12), e1688-e1696, 2021 | 66 | 2021 |
| SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination F Liew, S Talwar, A Cross, BJ Willett, S Scott, N Logan, MK Siggins, ... EBioMedicine 87, 2023 | 62 | 2023 |
| The Typhoid Vaccine Acceleration Consortium (TyVAC): vaccine effectiveness study designs: accelerating the introduction of typhoid conjugate vaccines and reducing the global … JE Meiring, M Gibani, B Basnyat, AD Bentsi-Enchill, J Clemens, ... Vaccine 35 (38), 5081-5088, 2017 | 47 | 2017 |
| The surveillance for enteric fever in Asia project (SEAP), severe typhoid fever surveillance in Africa (SETA), surveillance of enteric fever in India (SEFI), and strategic … ME Carey, WR MacWright, J Im, JE Meiring, MM Gibani, SE Park, ... Clinical Infectious Diseases 71 (Supplement_2), S102-S110, 2020 | 43 | 2020 |
| Effects of pre‐operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study COVIDSurg Collaborative, GlobalSurg Collaborative, D Nepogodiev, ... Anaesthesia 76 (11), 1454-1464, 2021 | 42 | 2021 |
| The invisible burden: diagnosing and combatting typhoid fever in Asia and Africa VE Pitzer, J Meiring, FP Martineau, CH Watson, G Kang, B Basnyat, ... Clinical Infectious Diseases 69 (Supplement_5), S395-S401, 2019 | 39 | 2019 |
| Typhoid Vaccine Acceleration Consortium Malawi: a phase III, randomized, double-blind, controlled trial of the clinical efficacy of typhoid conjugate vaccine among children in … JE Meiring, MB Laurens, P Patel, P Patel, T Misiri, K Simiyu, ... Clinical Infectious Diseases 68 (Supplement_2), S50-S58, 2019 | 30 | 2019 |
Melita A GordonProfessor of Gastroenterology, University of LiverpolVerified email at liv.ac.uk
